Dear Dr. Michelle, Is it true that there is a new treatment for Alzheimer’s disease that slows it down? This is a question I’ve been asked repeatedly over the past month. The most recently approved medication for Alzheimer’s disease is Biogen’s aducanumab (Aduhelm). The FDA approved this drug in June of 2021, even though scientific […]
Blog
Memory Matters – Dec 2022
DEAR DR. MICHELLE, What about supplements, like Prevagen or CoQ10? Should I be taking those? The “nutraceutical” industry is not controlled the same way the pharmaceutical industry is, and evidence to support the use of supplements as “brain boosters” is still lacking. Claims about the effectiveness and safety of these products are not necessarily based […]
Memory Matters – November 2022
DEAR DR. MICHELLE, What do you think about Lumosity? Do brain games work? Keeping your mind engaged contributes to healthy brain aging. If you like playing computer games offered by Lumosity and other websites, go for it! Or you can read, cook, or garden. You can also exercise your brain with Sudoku or crossword puzzles […]
New Alzheimer’s Drug Announces Results
Last week, Eisai and Biogen announced significant results of its Phase 3 clinical trial of the drug lecanamab. Lecanamab is a monoclonal antibody that targets an early stage of the amyloid protein that forms plaques in the brains of people with Alzheimer’s disease. During an 18-month study in which 1795 participants received either drug or […]
Benefits of Clinical Trials: A Proactive Approach to Your Brain Health
What are Clinical Trials? Clinical trials are research studies in which treatments or diagnostic tools are tested for safety and efficacy. At The CRCNJ, we conduct clinical trials focused on memory loss, Alzheimer’s disease, Mild Cognitive Impairment, and dementia. What are the Benefits of Clinical Trials? Currently, 1 in 3 older adults die of Alzheimer’s […]
Diagnosing Alzheimer’s Disease: Access to Specialized Scans
Alzheimer’s disease research has made great advances in testing and imaging. Scientists are investigating a number of disease markers and diagnostic tests, which may accurately and reliably indicate whether a person has Alzheimer’s disease and how far it has progressed. Some of these tests use cutting-edge technology and are not widely available yet, so participation […]
